Skip to Main Content Skip to Main Content

HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: Big 4 Journals

Big 4 Journals current awareness bulletin

Frequency: weekly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To access articles, click on displayed links, and log in with your Healthcare Library number and password if prompted. For guidance on logging in, please go to: https://healthcarelibrary.qub.ac.uk/LogginginonTrustdevices/

To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk

This bulletin is based on the equivalent bulletin produced by Bodleian Health Care Libraries:

8th September 2025

The BMJ: 8th September 2025

Facing a smear test after my trauma

Heatwaves: how air pollution is worsening effects on health

Time restricted eating and exercise training before and during pregnancy for people with increased risk of gestational diabetes: single centre randomised controlled trial (BEFORE THE BEGINNING)

What adjustments can I ask for as a pregnant doctor?

JAMA: 9th September 2025

Dalbavancin for treatment of Staphylococcus aureus bacteremia: the DOTS randomized clinical trial

In utero embolization for fetal vein of Galen malformation

Osteoporosis: a review

Reducing barriers to mental health care for physicians: an overview and strategic recommendations

The Lancet: 13th September 2025

β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials

Cardiovascular, kidney, and metabolic health: an actionable vision for heart failure prevention

Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis

Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial

Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial

Prioritising the primary prevention of heart failure

Prevention of heart failure after acute myocardial infarction

New England Journal of Medicine: 11th September 2025

Aficamten or metoprolol monotherapy for obstructive hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy

Marburg virus disease in Rwanda, 2024 — public health and clinical responses

Mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy

Medications for opioid use disorder in county Jails — outcomes after release

Multidomain rehabilitation for older patients with myocardial infarction

The race-correction debates — progress, tensions, and future directions

1st September 2025

The BMJ: 1st September 2025

Can humanitarian aid organisations afford to stay neutral?

Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis

Improving the reporting on health equity in observational research (STROBE-Equity): extension checklist and elaboration

Reducing unnecessary imaging in ankle and foot trauma

Transparent reporting of observational studies emulating a target trial: the TARGET Statement

Weapons of influence: tactics of a growing global arms industry and needed health actions

Weapons, wealth, and health: the arms industry as a commercial determinant of health

What is the evidence for school smartphone bans?

JAMA: 2nd September 2025

Alteplase for acute ischemic stroke at 4.5 to 24 hours: the HOPE randomized clinical trial

Ethical obligations to inform patients about use of AI tools

Lower urinary tract symptoms in men: a review

Management of Staphylococcus aureus bacteremia: a review

Population health colorectal cancer screening strategies in adults aged 45 to 49 years

The Lancet: 6th September 2025

Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials

Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION–STEMI)

Influenza vaccination to improve outcomes for patients with acute heart failure (PANDA II): a multiregional, seasonal, hospital-based, cluster-randomised, controlled trial in China

The Lancet Countdown on health and plastics

New England Journal of Medicine: 4th September 2025

Management of acute type B aortic dissection

Monoclonal antibodies in the pathogenesis of heparin-induced thrombocytopenia

Once-monthly maridebart cafraglutide for the treatment of obesity — a phase 2 trial

One dose versus three doses of benzathine penicillin G in early syphilis

Stem cell–derived, fully differentiated islets for type 1 diabetes

Survival of transplanted allogeneic beta cells with no immunosuppression

Ultrasound-guided paracentesis

Disclaimer

The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.